Yiqi Huoxue Demolition and Recipes on Recovery Stage of Cerebral Infarction

• Status: Unknown status
• Trial end date: 2019-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This clinical research is based on the fundamentals of using Chinese medicine, which will improve Qi and promote blood circulation, to treat patients in the recuperating stages of cerebral infarction with deficiency in Qi and blood stasis syndrome. By assimilating Chinese medical theory, this research aims to study the biological basics of the stroke and the cause for the deficiency in Qi and blood stasis syndrome; explore the therapeutic mechanism of the treatment methods; as well as ascertaining the relationship between Qi, blood and blood vessels.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Dongfang Hospital Affiliated to Beijing University of Chinese Medicine; Dongfang Hospital Beijing University of Chinese Medicine
• Collaborators: The First Affiliated Hospital of Henan University of Traditional Chinese Medicine; Xingtai People's Hospital

Criteria

Inclusion Criteria:

1. In accordance to the Western medicine diagnostic criteria for atherosclerotic thrombotic cerebral infarction;

2. In accordance to the Chinese medicine diagnostic criteria for stroke, with deficiency in Qi and blood stasis syndrome;

3. In accordance to Stroke's diagnostic scale factor standards: asthenic Qi syndrome ≥ 10 points, blood stasis ≥ 10 points;

4. Within the recuperating stage of the illness (2 weeks to 6 months);

5. National Institutes of Health Stroke Scale (NIHSS) with a score of 3-22 points;

6. Ages within 35-80;

7. Signature of consent to participate in the research.

Exclusion Criteria:

1. Patients suffering from transient ischemic attack (TIA), subarachnoid haemorrhage and cerebral haemorrhage;

2. Patients suffering from cerebral embolism due to superficiality extremities caused by rheumatic heart disease, coronary heart disease and other heart diseases coupled with atrial fibrillation; stroke patients caused by brain tumor, head trauma, blood diseases, etc;

3. Pregnant women or women planning for pregnancy, women with positive urine pregnancy test, and lactating women;

4. Patients with severe hepatic and renal dysfunction, severe disease of the hematopoietic system, highly active ulcer and bleeding tendency, severe disease of the endocrine system, severe bone and joint disease, and arrhythmia patients with great clinical significance;

5. Patients with mental impairment, or mental disability, or severely deaf, or unconscious, or being uncooperative during inspection;

6. Patients with known allergies to the medicine used, as well as overly sensitive patients;

7. Patients that underwent clinical trials within the past 3 months.